source
- Some U.S. Employers Plan to End GLP-1 Obesity Drug Coverage in 2027, Even as Prices FallA Reuters report says roughly 10% of U.S. employers that currently cover GLP-1 medicines for weight loss intend to stop covering them in 2027. The move comes as enrollment in obesity-treating drugs…
- Neion Bio secures $23M Series A to develop egg-based protein platform for biologicsNeion Bio announced it closed a $23 million Series A round that was oversubscribed. The funding will be used to advance its platform that leverages chicken eggs, extracting primordial germ cells f…